Royalty Pharma plc Class A Ordinary Shares vs Viking Holdings Ltd Ordinary Shares — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Viking Holdings Ltd Ordinary Shares trades at $81.62 (market cap $36.29B). The key difference: Viking Holdings Ltd Ordinary Shares is the larger of the two by market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Viking Holdings Ltd Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Viking Holdings Ltd Ordinary Shares for 0 Days on average.
| RPRX | VIK | |
|---|---|---|
Market Cap | $25.27B | $36.29B |
Volume | 3,671,183 | 2,522,956 |
Sector | Health | Consumer Cyclical |
52-Week High | $63.96 | $108.26 |
52-Week Low | $35.44 | $57.08 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $32.50B | $38.67B |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →Viking operates river, ocean, and expedition cruises. Its itineraries focus on destination-based travel across Europe, the Americas, and other regions.
Read more on VIK →